Price targets set by research firms often influence the stock prices of companies. In this case, Zacks Small-Cap Research's $26 price valuation for Lantern Pharma could potentially lead to an increase in its stock price, assuming the current price is below the target. This is because investors may buy the stock anticipating it will reach or exceed the target price.